A veteran weaving company with three decades of expertise in medical gauze has decided to invest 20 million yuan to fill a gap in deep processing. The Xinda Textile medical textile expansion and chain-completion project in Yuekou, Tianmen, Hubei, will start construction in September. The company is introducing 30 automated gauze folding machines, targeting an annual output of 96 million meters of medical grey fabric and an annual output value exceeding 100 million yuan. This seemingly modest regional expansion reflects a clear signal of vertical integration in the medical textile industrial chain.
From Weaving to Finished Products: The Cost and Efficiency Logic Behind Integration
Previously, Xinda Textile focused on weaving medical grey fabric, an intermediate product with limited added value and high sensitivity to upstream cotton and yarn price fluctuations. The new project centers on automated gauze folding equipment, enabling direct processing of grey fabric into finished medical dressings. This allows the company to bypass middlemen and connect directly with end buyers such as hospitals and pharmacies. From an industry perspective, the cost advantage of integrated production is direct: eliminating multiple logistics, warehousing, and intermediary markups can boost profit margins from 5%-8% for grey fabric to 15%-20% for finished products. For buyers, this means more stable pricing and shorter delivery times.
A 20 Million Yuan Investment Driving Regional Medical Textile Upgrades
Tianmen is not a traditional textile powerhouse, but Yuekou town hosts a cluster of medical gauze weaving enterprises. Xinda's expansion, with 20 million yuan and 30 automated machines, may be small in scale, but its demonstration effect is significant. It shows that even small and medium-sized enterprises in the medical dressing field are actively transitioning from 'selling semi-finished products' to 'selling finished products.' This transformation is crucial for the local industrial chain: upstream cotton yarn suppliers gain more stable downstream customers, while downstream medical device distributors or hospitals can source locally, reducing cross-regional logistics and time costs.
The Medical Gauze Market: Capacity Race Under Rigid Demand
Medical gauze is a low-value consumable but with rigid demand. Whether for routine medical care, surgery, or emergency stockpiles, it is indispensable. In recent years, with higher hospital infection control standards in China and growing demand from Belt and Road countries, Chinese exports of medical dressings have expanded. Chinese Customs data shows medical dressing exports grew about 12% year-on-year in 2025, with gauze products accounting for over 30%. In this context, Xinda's expansion is not blind; it is based on long-term customer relationships and identified regional market gaps. Annual output of 96 million meters of medical grey fabric adds a medium-sized supply line for central China.
Automation Replacing Labor: An Inevitable Response to Rising Costs
Gauze folding has long been labor-intensive, especially for complex specifications, requiring months to train skilled workers. As labor costs rise and younger workers shy away from traditional textile workshops, automation becomes inevitable. The 30 automated folding machines can each replace 3-5 skilled workers, with higher folding precision and consistency. For Xinda, this reduces long-term labor costs and minimizes quality fluctuations from personnel turnover. For downstream buyers, automated production means more uniform product specifications and lower defect rates—critical in medical applications where folding methods and dimensional tolerances must meet strict standards.